March 7, 2011 – Each year between 100,000 and 180,000 Americans die as the result of pulmonary embolism, a complication from blood clots in the lungs. The Vascular Disease Foundation urges Americans, especially women, to learn about the risks of venous blood clots to help prevent these deaths.

March 7, 2011 – Last week Medtronic Inc. cancelled its five contracts with Novation LLC, one of the largest U.S. group purchasing organizations (GPOs), which previously represented $2 billion. The contracts included reduced price, large group purchases of cardiovascular and orthopedic devices.

March 7, 2011 – A pilot study testing a system designed to improve acute coronary syndrome (ACS) revascularization has been successfully completed. The study looked at the Picso Impulse System, from Miraco Medical, which is used following primary percutaneous coronary intervention (PCI) to diminish ischemia.

March 4, 2011 - Occlutech GmbH received a favorable court ruling in Stockholm, Sweden in the ongoing patent litigation case with AGA Medical-St. Jude Medical.

March 4, 2011 – A new generation of a mobile C-arm has been launched, offering outstanding imaging and a liquid cooling system to allow use over an almost unlimited period of time. The Vision RFD mobile C-arm, from Ziehm, is an alternative to fixed installations in hybrid operating rooms (ORs), especially for hospitals with space and budgetary constraints.

Boston Scientific has completed its acquisition of Atritech. The completion of the transaction follows the signing of a definitive merger agreement announced on Jan. 19, 2011.

March 4, 2011 – The U.S. Food and Drug Administration (FDA) recently cleared two new magnetic resonance (MR) systems. Approximately 180 Optima MR360 1.5 Tesla and Brivo MR355 1.5 Tesla scanners, from GE Healthcare, have been ordered by hospitals and imaging centers worldwide.

March 4, 2011 – According to a retrospective sub-study of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), there is no evidence that implantable cardioverter defibrillator (ICD) benefit varies with time from myocardial infarction (MI) to device implantation. Accordingly, single lead ICD benefit is not restricted to patients with a remote MI (more than 18 months).

March 2, 2011 – Despite a long-standing requirement for medical device makers to include women in studies they submit to the U.S. Food and Drug Administration (FDA) for approval, only a few include enough or analyze how the devices work specifically in women, according to research in Circulation: Cardiovascular Quality and Outcomes.

March 2, 2011 – A new transseptal puncture module for education and simulation technology has been released. The module is for Simbionix’ Angio Mentor simulator.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now